Phase 1 7 trials
Phase 1
NCT01634685 Aug 2012 → Oct 2015 rectum adenocarcinoma University of Texas Southwestern Medical Center
Completed
No outcome recorded
Phase 1
NCT01323062 May 2011 → May 2014 non-small cell lung carcinoma UNC Lineberger Comprehensive Cancer Center
Completed
No outcome recorded
Phase 1
NCT01288261 Jan 2011 → May 2013 Her2-receptor negative breast cancer , male breast carcinoma University of Arizona
Completed
No outcome recorded
Phase 1
NCT00503347 Jul 2007 → Mar 2011 HIV infectious disease , chronic hepatitis C virus infection Peregrine Pharmaceuticals
Completed
No outcome recorded
Phase 1
NCT00343525 May 2006 → Jan 2007 hepatitis C virus infection Peregrine Pharmaceuticals
Completed
No outcome recorded
Phase 1
NCT00128271 Aug 2005 → Aug 2006 chronic hepatitis C virus infection Peregrine Pharmaceuticals
Completed
No outcome recorded
Phase 1
NCT00129337 Jun 2005 → Aug 2009 neoplasm Peregrine Pharmaceuticals
Completed
No outcome recorded
Phase 1/2 3 trials
Phase 1/2
NCT01335204 Jun 2011 → Mar 2013 prostate cancer Medical University of South Carolina
Terminated
No outcome recorded
Phase 1/2
NCT01264705 Jan 2011 → Apr 2018 hepatocellular carcinoma University of Texas Southwestern Medical Center
Completed
No outcome recorded
Phase 1/2
NCT01273948 Jan 2011 → Jan 2012 hepatitis C virus infection Peregrine Pharmaceuticals
Completed
No outcome recorded
Phase 2 13 trials
Phase 2
NCT05249569 Nov → Dec 2022 hepatocellular carcinoma University of Texas Southwestern Medical Center
Terminated
No outcome recorded
Phase 2
NCT04150900 Jan 2020 → Sep 2024 overdue squamous cell carcinoma University of Maryland, Baltimore
Active not recruiting
No outcome recorded
Phase 2
NCT04099641 Sep 2019 → Dec 2021 gastric cancer , gastroesophageal cancer OncXerna Theraputics, Inc.
Completed
No outcome recorded
Phase 2
NCT03519997 Apr 2018 → Apr 2023 hepatocellular carcinoma David Hsieh
Completed
No outcome recorded
Phase 2
NCT03139916 Sep 2017 → Aug 2022 glioblastoma Massachusetts General Hospital
Completed
No outcome recorded
Phase 2
NCT02685306 Mar 2016 → Apr 2017 triple-negative breast carcinoma Peregrine Pharmaceuticals
Withdrawn
No outcome recorded
Phase 2
NCT02673814 Feb 2016 → Apr 2017 non-small cell lung carcinoma Peregrine Pharmaceuticals
Withdrawn
No outcome recorded
Phase 2
NCT01272791 Jan 2011 → Feb 2013 malignant pancreatic neoplasm Peregrine Pharmaceuticals
Completed
No outcome recorded
Phase 2
NCT01160601 Jun 2010 → Jun 2013 non-small cell lung carcinoma Peregrine Pharmaceuticals
Completed
No outcome recorded
Phase 2
NCT01138163 Jun 2010 → Oct 2012 non-small cell lung carcinoma Peregrine Pharmaceuticals
Completed
No outcome recorded
Phase 2
NCT00669565 Jul 2008 → Jul 2010 breast carcinoma Peregrine Pharmaceuticals
Completed
No outcome recorded
Phase 2
NCT00687817 Jun 2008 → Jul 2010 non-small cell lung carcinoma Peregrine Pharmaceuticals
Completed
No outcome recorded
Phase 2
NCT00669591 Jan 2008 → Jun 2010 breast cancer Peregrine Pharmaceuticals
Completed
No outcome recorded
Show 3 more trials Phase 2/3 1 trial
Phase 2/3
NCT02651610 Dec 2015 → Dec 2017 breast cancer Peregrine Pharmaceuticals
Withdrawn
No outcome recorded
Phase 3 1 trial
Phase 3
NCT01999673 Dec 2013 → Mar 2017 non-small cell lung carcinoma Peregrine Pharmaceuticals
Completed
No outcome recorded